share_log

Evelo Biosciences Q4 EPS $(0.62) Misses $(0.53) Estimate

Evelo Biosciences Q4 EPS $(0.62) Misses $(0.53) Estimate

Velo Biosciences第四季度每股收益$(0.62)$(0.53)估计
Benzinga Real-time News ·  2021/03/09 20:24

Evelo Biosciences (NASDAQ:EVLO) reported quarterly losses of $(0.62) per share which missed the analyst consensus estimate of $(0.53) by 16.98 percent. This is a 11.43 percent increase over losses of $(0.70) per share from the same period last year.

Evelo Biosciences(纳斯达克：EVLO)公布季度亏损(0.62美元/股)，低于分析师普遍预期的0.53美元(0.53美元)16.98%。这比去年同期每股亏损0.70美元增加了11.43%。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发